Ra Pharmaceuticals Receives $8,600,000 Series A Financing Round

  • Feed Type
  • Date
    5/16/2012
  • Company Name
    Ra Pharmaceuticals
  • Mailing Address
    One Kendall Square Cambridge, MA 02139
  • Company Description
    Ra Pharma is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma’s peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability.
  • Website
    http://www.rapharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,600,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    2nd tranche. We will continue to build out our pipeline using our high-diversity drug discovery platform capable of generating optimized lead candidates in a matter of weeks, but also hope to secure discovery and development partnerships as we gain momentum with our internal programs.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Amgen Ventures